Overview
The Tokyo Consortium aims to support the social implementation of innovation by accelerating the growth of startups and forming a startup ecosystem in the Tokyo area. In the bio-wellness field, we are working to create open innovation between large companies and startups, including medical care, drug discovery, and healthcare, and to grow the bio-ecosystem in the Tokyo area.
At this event, we will collaborate with the Greater Tokyo Biocommunity and Bioindustry Association to discuss the current situation surrounding bioecosystems and future prospects using various fact data.
We are planning a panel discussion inviting people from startups, large companies, investors, and academia who are active on the front lines of the bioecosystem. This is a valuable opportunity to hear from a leading expert on the possibilities of the future bioecosystem in the Tokyo area, so please join us!
We are also planning a networking event, so please consider attending not only as an opportunity to gather information, but also as a networking opportunity.
*This event is not scheduled to be streamed online.
Agenda
-
[17:00-17:10]
Greater Tokyo Biocommunity’s bioecosystem “visualization” efforts (Greater Tokyo Biocommunity)
-
[17:10-17:20]
Explanation on the current status of the bioecosystem in the Tokyo area (Secretariat)
-
[17:20-18:20]
Panel discussion on bioecosystems in the Tokyo area
-
[18:20-18:30]
Introduction of initiatives by Tokyo Consortium members (JETRO, Link-J)
-
[18:30-19:00]
Business card exchange/networking *Optional participation
*Agenda and time are subject to change.
Speaker profile
-
Methuselah Co., Ltd.
Representative Director Co-Founder, Co-CEO Kenichi Nogami
March 2008: Graduated from the University of Tsukuba, School of International Studies.
Since 2008, he has worked in the investment banking division of Sumitomo Mitsui Banking Corporation, and in 2010 he has worked in the investment banking division of Morgan Stanley Securities, where he has been involved in corporate acquisitions and financing.
In 2014, he became the head of the corporate planning department of an e-commerce related startup, and while being involved in overall management of the startup, he also participated in the commercialization of Methuselah from the same year.
As co-representative of Methuselah, he oversees business execution including development strategy planning, business model construction, and financing.
-
Fast Track Initiative Co., Ltd.
Principal Hiroko Kimura
Graduated from the Department of Biochemistry, Faculty of Science, University of Tokyo, and completed doctoral course at the same university's Graduate School of Medicine.
Joined Sigmaxis Co., Ltd. and engaged in management consulting and M&A advisory activities in the strategy group.
Participated in the Fast Track Initiative since August 2013, mainly engaged in investment evaluation and management support for startup companies in the bio field (drug discovery basic technology, drug discovery and development, regenerative medicine, medical devices, etc.), and participated as an outside director. .
Until March 2017, he concurrently served as a specially appointed assistant professor at the Graduate School of Pharmaceutical Sciences, the University of Tokyo. His supervised translation is ``A Practical Guide to Academia Drug Discovery: Translational Research Using Stanford University SPARK'' (University of Tokyo Press).
-
Deputy Director, Tokyo Medical and Dental University (in charge of industry-academia-government collaboration and open innovation)
Professor Kaori Iida, Deputy Director, Open Innovation Center, Institute for Integrated Innovation
After joining Tokyo Medical and Dental University, a national university corporation, in 2005, engaged in planning and planning related to promotion of industry-academia collaboration and open innovation activities, development of entrepreneurial environment, and industry-academia collaboration practices and education, including risk management such as intellectual property and conflicts of interest. . Her research themes are the medical innovation environment and industry-academia collaboration risk management.
Visiting professor at Hiroshima University, part-time lecturer at Keio University, advisor to TMC of the National Center for Neurology and Psychiatry, executive director of the Medical Industry-Academia Collaboration Network Council (medU-net), vice president of the Society for Industry-Academia Collaboration, and member of the Japanese Society of Internal Medicine and other medical institutions. He also serves as an ethics/COI committee member for academic societies, universities, and other academia.
-
Takeda Pharmaceutical Company Limited
Japan Pharma Business Unit Data, Digital & Technology Department Digital Acceleration Innovation Lead Taruho Kuroda
After completing the doctoral course at Hokkaido University Graduate School, he worked as an academic researcher at RIKEN, Harvard Medical School, and Mie University School of Medicine for a total of 10 years, engaging in anti-cancer drug development and basic research on skin diseases.
Worked in open innovation departments at two foreign pharmaceutical companies. In addition to his main job, he is engaged in building startup ecosystems in the life science and healthcare fields through various multi-business and personal businesses including venture capital.
Current position from October 2023.
Business introduction corner
Speaker profile
-
Japan External Trade Organization (JETRO)
Mr. Taku Sato, Manager of Overseas Expansion Support Department (Healthcare Industry)
Since joining JETRO in 1993, he has been involved in supporting overseas expansion of startups mainly in the life science field and attracting foreign capital for over 20 years. He assumed his current position after serving as director of the New York office, corporate attraction section manager, healthcare industry section manager, Chiba office manager, etc. He has given numerous lectures both domestically and internationally, including BIO in the US, UC Irvine, MassMedic, BIO-Europe in Germany, and MEDICA.
Chiba University Visiting Professor, Hosei University Innovation Management Research Center Visiting Researcher/GGLI Fellow, Ryutsu Keizai University Visiting Lecturer, Greater Tokyo Biocommunity Council Practitioner Council Member, Chiba Prefecture Bio-Life Science Network Conference Planning and Management Committee Member, Chiba Health and Medical Care Serves as an advisor to the Manufacturing Industry Support Promotion Council.
Graduated from the Department of Foreign Studies, Tokyo University of Foreign Studies, completed the Master's degree in Business Administration (MBA) at Hosei University Graduate School, and completed the Medical Innovation Strategy Program at Chiba University School of Medicine.
-
Group Manager, Innovation Promotion Group, Life Science Innovation Promotion Department, Mitsui Fudosan Co., Ltd.
Mr. Hiroshi Asahina, General Incorporated Association, Business Division, Life Science Innovation Network Japan
After joining Mitsui Fudosan Co., Ltd. in 2000, he worked in the housing business and Nihonbashi area management business before assuming his current position.
Taking advantage of the characteristics of the Nihonbashi area, which is a "city of medicine," he was involved in the establishment of LINK-J, a company that will become a hub for open innovation that goes beyond the traditional real estate business.
Currently, we are building a community that connects industry, government, and academia.
-
Date and Time
Monday, December 2023, 12 11:17-00:19 (doors open at 00:16)
-
Venue
Tokyo Innovation Base
SusHi Tech Square 3F, 8-3-2 Marunouchi, Chiyoda-ku, Tokyo
https://tib.metro.tokyo.lg.jp/#access
-
Entry fee
Free
-
Capacity
150 people
-
Sponsorship
Startup Ecosystem Tokyo Consortium
-
Planning cooperation
Greater Tokyo Biocommunity (GTB), Japan Bioindustry Association
-
How to apply
Please apply for participation using the application form below.
https://forms.office.com/e/27D7TT6xR5
-
Application date
Monday, May 2023, 12 11:12
*The registration will be closed once the capacity is reached.
-
Disclaimer
Please refrain from taking video or recording during the lecture.
-
Contact
Tokyo Consortium Management Office tokyo_consortium@tohmatsu.co.jp
Management Trustee: Tohmatsu Limited Liability Audit Corporation
Reception/Answer time: 10:00-17:00 (excluding Saturdays, Sundays, and holidays)
